DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 214 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,436 | +2.6% | 842 | -10.2% | 0.00% | – |
Q2 2023 | $12,119 | -59.1% | 938 | -68.9% | 0.00% | – |
Q1 2023 | $29,607 | -14.5% | 3,018 | -7.3% | 0.00% | – |
Q4 2022 | $34,633 | +147.4% | 3,255 | +141.5% | 0.00% | – |
Q3 2022 | $14,000 | -39.1% | 1,348 | -25.6% | 0.00% | – |
Q2 2022 | $23,000 | +15.0% | 1,813 | 0.0% | 0.00% | – |
Q1 2022 | $20,000 | -23.1% | 1,813 | 0.0% | 0.00% | – |
Q4 2021 | $26,000 | -33.3% | 1,813 | -11.9% | 0.00% | – |
Q3 2021 | $39,000 | +95.0% | 2,058 | 0.0% | 0.00% | – |
Q2 2021 | $20,000 | -16.7% | 2,058 | -13.4% | 0.00% | – |
Q1 2021 | $24,000 | +166.7% | 2,377 | +15.5% | 0.00% | – |
Q4 2020 | $9,000 | +200.0% | 2,058 | +195.3% | 0.00% | – |
Q3 2020 | $3,000 | -50.0% | 697 | 0.0% | 0.00% | – |
Q2 2020 | $6,000 | -87.0% | 697 | -71.1% | 0.00% | – |
Q1 2016 | $46,000 | -20.7% | 2,415 | 0.0% | 0.00% | – |
Q4 2015 | $58,000 | – | 2,415 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |